• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Smad4 依赖的转化生长因子-β信号传导抑制 RON 受体酪氨酸激酶依赖的胰腺癌细胞迁移和侵袭。

Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells.

作者信息

Zhao Shujie, Ammanamanchi Sudhakar, Brattain Michael, Cao Lin, Thangasamy Amalraj, Wang Jing, Freeman James W

机构信息

Department of Medicine, Division of Medical Oncology, University of Texas Health Science Center, San Antonio, Texas 78229-3900, USA.

出版信息

J Biol Chem. 2008 Apr 25;283(17):11293-301. doi: 10.1074/jbc.M800154200. Epub 2008 Feb 29.

DOI:10.1074/jbc.M800154200
PMID:18310076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2431051/
Abstract

Transforming growth factorbeta (TGF-beta) signals through Smad-dependent and Smad-independent pathways. However, Smad signaling is altered by allelic deletion or intragenic mutation of the Smad4 gene in more than half of pancreatic ductal adenocarcinomas. We show here that loss of Smad4-dependent signaling leads to aberrant expression of RON, a phosphotyrosine kinase receptor, and that signaling by RON cooperates with Smad4-independent TGF-beta signaling to promote cell motility and invasion. Restoring Smad4 expression in a pancreatic ductal adenocarcinoma cell line that is deficient in Smad4 repressed RON expression. Conversely, small interference RNA knock down of Smad4 or blocking TGF-beta signaling with a TGF-beta type I receptor kinase inhibitor in Smad4-intact cell lines induced RON expression. TGF-beta-induced motility and invasion were inhibited in cells that express Smad4 and that have low levels of RON compared with isogenically matched cells that were deficient in Smad4. Furthermore, knocking down RON expression in Smad4-deficient cells suppressed TGF-beta-mediated motility and invasion. We further determined that Smad4-dependent signaling regulated RON expression at the transcriptional level by real-time reverse transcription PCR and RON promoter luciferase reporter assays. Functional inactivation by site-directed mutations of two Smad binding sites on the RON promoter inhibited TGF-beta-mediated repression of RON promoter activity. These studies indicate that loss of Smad4 contributes to aberrant RON expression and that cross-talk of Smad4-independent TGF-beta signaling and the RON pathway promotes an invasive phenotype.

摘要

转化生长因子β(TGF-β)通过Smad依赖和Smad非依赖途径发出信号。然而,在超过一半的胰腺导管腺癌中,Smad4基因的等位基因缺失或基因内突变会改变Smad信号传导。我们在此表明,Smad4依赖信号的缺失导致磷酸酪氨酸激酶受体RON的异常表达,并且RON信号与Smad4非依赖的TGF-β信号协同作用以促进细胞运动和侵袭。在缺乏Smad4的胰腺导管腺癌细胞系中恢复Smad4表达可抑制RON表达。相反,在Smad4完整的细胞系中,用小干扰RNA敲低Smad4或用TGF-β I型受体激酶抑制剂阻断TGF-β信号会诱导RON表达。与缺乏Smad4的同基因匹配细胞相比,在表达Smad4且RON水平较低的细胞中,TGF-β诱导的运动和侵袭受到抑制。此外,在缺乏Smad4的细胞中敲低RON表达可抑制TGF-β介导的运动和侵袭。我们通过实时逆转录PCR和RON启动子荧光素酶报告基因检测进一步确定,Smad4依赖信号在转录水平上调节RON表达。通过对RON启动子上两个Smad结合位点进行定点突变使其功能失活,可抑制TGF-β介导的RON启动子活性的抑制。这些研究表明,Smad4的缺失导致RON异常表达,并且Smad4非依赖的TGF-β信号与RON途径的相互作用促进了侵袭性表型。

相似文献

1
Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells.Smad4 依赖的转化生长因子-β信号传导抑制 RON 受体酪氨酸激酶依赖的胰腺癌细胞迁移和侵袭。
J Biol Chem. 2008 Apr 25;283(17):11293-301. doi: 10.1074/jbc.M800154200. Epub 2008 Feb 29.
2
Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.靶向SMAD4缺陷型人胰腺癌细胞中的内源性转化生长因子β受体信号传导可抑制其侵袭性表型1。
Cancer Res. 2004 Aug 1;64(15):5200-11. doi: 10.1158/0008-5472.CAN-04-0018.
3
Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling.通过诱导性恢复TGF-β信号传导深入了解胰腺癌中SMAD4的缺失
Mol Endocrinol. 2015 Oct;29(10):1440-53. doi: 10.1210/me.2015-1102. Epub 2015 Aug 18.
4
Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.Smad4/DPC4对人胰腺癌细胞肿瘤发生的抑制作用及p15(ink4b)的诱导
Clin Cancer Res. 2002 Nov;8(11):3628-38.
5
Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.利用稳定RNA干扰和转化生长因子-β诱导的基因表达谱在胰腺癌细胞系中沉默Smad4
Oncogene. 2005 Jan 20;24(4):662-71. doi: 10.1038/sj.onc.1208102.
6
MicroRNA-362 negatively and positively regulates SMAD4 expression in TGF-β/SMAD signaling to suppress cell migration and invasion.微小 RNA-362 在 TGF-β/SMAD 信号中负向和正向调控 SMAD4 表达,抑制细胞迁移和侵袭。
Int J Med Sci. 2021 Feb 18;18(8):1798-1809. doi: 10.7150/ijms.50871. eCollection 2021.
7
A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.人MUC4粘蛋白基因(ErbB2配体)作为转化生长因子-β在胰腺癌发生过程中的一个靶点所起的作用。
Oncogene. 2004 Jul 29;23(34):5729-38. doi: 10.1038/sj.onc.1207769.
8
Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.胰腺肿瘤细胞中转化生长因子-β通过Smad4/DPC4依赖性调控双糖链蛋白聚糖基因表达
J Biol Chem. 2002 Sep 27;277(39):36118-28. doi: 10.1074/jbc.M203709200. Epub 2002 Jul 24.
9
SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.SMAD4 缺失触发胰腺导管腺癌细胞的表型改变。
BMC Cancer. 2014 Mar 14;14:181. doi: 10.1186/1471-2407-14-181.
10
PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor-β (TGF-β) signaling.PDZK1 相互作用蛋白 1(PDZK1IP1)捕获 Smad4 蛋白并抑制转化生长因子-β(TGF-β)信号。
J Biol Chem. 2019 Mar 29;294(13):4966-4980. doi: 10.1074/jbc.RA118.004153. Epub 2019 Feb 4.

引用本文的文献

1
MSP-RON signaling in liver pathobiology and as an emerging therapeutic target: a review of the current evidence.MSP-RON信号通路在肝脏病理生物学中的作用及作为新兴治疗靶点的研究现状:现有证据综述
Cell Commun Signal. 2025 Aug 28;23(1):385. doi: 10.1186/s12964-025-02407-5.
2
Small-molecule agents for cancer immunotherapy.用于癌症免疫治疗的小分子药物。
Acta Pharm Sin B. 2024 Mar;14(3):905-952. doi: 10.1016/j.apsb.2023.12.010. Epub 2023 Dec 16.
3
Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer.头颈部癌症中 c-MET/HGF 信号转导的调控分子机制。
Mol Cancer. 2022 Jan 26;21(1):31. doi: 10.1186/s12943-022-01503-1.
4
RON Mediates Tumor-Promoting Effects in Endometrial Adenocarcinoma.RON 介导子宫内膜腺癌的肿瘤促进作用。
Biomed Res Int. 2021 Oct 19;2021:2282916. doi: 10.1155/2021/2282916. eCollection 2021.
5
CMTM8 as an LPA1-associated partner mediates lysophosphatidic acid-induced pancreatic cancer metastasis.作为与LPA1相关的伴侣蛋白,CMTM8介导溶血磷脂酸诱导的胰腺癌转移。
Ann Transl Med. 2021 Jan;9(1):42. doi: 10.21037/atm-20-1013.
6
Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer.异常的RON和MET共过表达作为胰腺癌患者生存期缩短的新型预后生物标志物及酪氨酸激酶抑制剂的治疗靶点
Front Oncol. 2019 Dec 5;9:1377. doi: 10.3389/fonc.2019.01377. eCollection 2019.
7
Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy.一种新型靶向癌症治疗的识别 RON 受体上的plexin-信号素-整合素结构域的人源化抗体药物偶联物的治疗效果。
J Immunother Cancer. 2019 Sep 13;7(1):250. doi: 10.1186/s40425-019-0732-8.
8
Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy.用于癌症治疗的靶向 RON 受体酪氨酸激酶的人源化抗体药物偶联物 Zt/g4-MMAE 的治疗效果、药代动力学特征和毒理学活性。
J Immunother Cancer. 2019 Mar 14;7(1):75. doi: 10.1186/s40425-019-0525-0.
9
Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer.前列腺癌中Ron受体表达的治疗考量
EMS Cancer Sci J. 2018;1(1). Epub 2018 Jul 30.
10
Automatic cell fusion via optically-induced dielectrophoresis and optically-induced locally-enhanced electric field on a microfluidic chip.通过微流控芯片上的光诱导介电泳和光诱导局部增强电场实现细胞自动融合。
Biomicrofluidics. 2018 May 22;12(3):034108. doi: 10.1063/1.5028158. eCollection 2018 May.

本文引用的文献

1
The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression.RON受体酪氨酸激酶介导胰腺癌细胞中的致癌表型,并且在胰腺癌进展过程中表达逐渐增加。
Cancer Res. 2007 Jul 1;67(13):6075-82. doi: 10.1158/0008-5472.CAN-06-4128.
2
PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma.纤溶酶原激活物抑制剂-1是突变型p53人皮肤鳞状细胞癌中转化生长因子-β1/表皮生长因子诱导的侵袭表型的关键上游调节因子。
J Biomed Biotechnol. 2007;2007(2):85208. doi: 10.1155/2007/85208. Epub 2007 Mar 20.
3
Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.人胰腺癌中的酪氨酸激酶受体RON:表达、功能及作为靶点的验证
Cancer. 2007 Mar 15;109(6):1030-9. doi: 10.1002/cncr.22490.
4
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.Smad4对于正常胰腺发育并非必需,但在胰腺癌的进展和肿瘤生物学中至关重要。
Genes Dev. 2006 Nov 15;20(22):3130-46. doi: 10.1101/gad.1478706.
5
Transforming growth factor-beta in cancer and metastasis.癌症与转移中的转化生长因子-β
Cancer Metastasis Rev. 2006 Sep;25(3):435-57. doi: 10.1007/s10555-006-9006-2.
6
Geldanamycins trigger a novel Ron degradative pathway, hampering oncogenic signaling.格尔德霉素触发一种新的Ron降解途径,阻碍致癌信号传导。
J Biol Chem. 2006 Aug 4;281(31):21710-21719. doi: 10.1074/jbc.M602014200. Epub 2006 Jun 1.
7
The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.肿瘤抑制因子Smad4是转化生长因子β诱导乳腺癌细胞上皮-间质转化和骨转移所必需的。
Cancer Res. 2006 Feb 15;66(4):2202-9. doi: 10.1158/0008-5472.CAN-05-3560.
8
Specificity and versatility in tgf-beta signaling through Smads.通过Smads蛋白实现的TGF-β信号传导的特异性和多功能性
Annu Rev Cell Dev Biol. 2005;21:659-93. doi: 10.1146/annurev.cellbio.21.022404.142018.
9
DNA microarray analysis of gene expression in eutopic endometrium from patients with deep endometriosis using laser capture microdissection.利用激光捕获显微切割技术对深部子宫内膜异位症患者在位子宫内膜基因表达进行DNA微阵列分析。
Fertil Steril. 2005 Oct;84 Suppl 2:1180-90. doi: 10.1016/j.fertnstert.2005.04.041.
10
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.由Smad肿瘤抑制通路介导的乳腺癌骨转移。
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13909-14. doi: 10.1073/pnas.0506517102. Epub 2005 Sep 19.